Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris
Abstract This is the first case of transient cervical lymphadenopathy as an adverse event during IVIg infusion. IVIg plays a vital role in the treatment of many dermatological conditions and identification of adverse events can facilitate patient counseling.
Main Authors: | Delila Pouldar Foulad, Michael Rigas, Fawad Piracha, Meeta Gupta, Maisie Nguyen, Sergei A. Grando, Shehla Memon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4763 |
Similar Items
-
Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic
by: Alberto Corrà, et al.
Published: (2021-08-01) -
Pemphigus vulgaris
by: Vijeev Vasudevan, et al.
Published: (2008-01-01) -
Pemphigus Vulgaris in the Mouth and Esophageal Mucosa
by: Angelo Gualberto de Macedo, et al.
Published: (2018-06-01) -
Pemphigus vulgaris and foliaceus localized to the nose: Report of 2 cases
by: Mohannad G. Safadi, BS, et al.
Published: (2021-09-01) -
Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris
by: Kyle T. Amber, et al.
Published: (2018-06-01)